TNXP Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company dedicated to the development of pharmaceutical products to address public health challenges. Its drug development program is focused on delivering treatment for PTSD.

$1.02  +0.05 (5.37%)
As of 03/05/2021 16:00:01 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
02/03/2012
323,914,331
45,980,139
$330,392,618
0.00%
SEC Edgar Online
10-Q
10-K
890260706
US8902607063
BK26FH7

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
0.16
0.00
-67.37%
0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy